BioSante Pharmaceuticals Announces Elestrin™ NDA Submission in Israel

Download Formats

• Thumbnail
  JPEG, 120x39, 4.5 KB
• Preview
  JPEG, 144x47, 5.8 KB
• Low Resolution
  JPEG, 300x99, 14.8 KB
• High Resolution
  JPEG, 476x158, 24.8 KB

Share This Logo